IMMUNITYBIO, INC. Earnings Per Share, Basic and Diluted
IMMUNITYBIO, INC. (IBRX) reported Earnings Per Share, Basic and Diluted of -$0.23 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-08-12
- IMMUNITYBIO, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.23.
- IMMUNITYBIO, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.21.
- IMMUNITYBIO, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.30.
- IMMUNITYBIO, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.20.
- IMMUNITYBIO, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.22.
- IMMUNITYBIO, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.20.
- IMMUNITYBIO, INC. earnings per share, basic and diluted for fiscal 2016 was -$1.47.
- IMMUNITYBIO, INC. earnings per share, basic and diluted for fiscal 2015 was -$3.31.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$0.23 10-Q · filed 2021-08-12 | -$0.44 10-Q · filed 2021-08-12 | ||||||
| 2021-03-31 | -$0.21 10-Q · filed 2021-05-14 | |||||||
| 2020-12-31 | -$0.30 10-K · filed 2021-03-04 | -$0.59 8-K/A · filed 2021-04-22 | -$0.89 10-K · filed 2021-03-04 | |||||
| 2020-09-30 | -$0.20 10-K · filed 2021-03-04 | -$0.59 10-Q · filed 2020-11-09 | ||||||
| 2020-06-30 | -$0.14 10-Q · filed 2021-08-12 | -$0.20 10-Q · filed 2020-08-07 | -$0.24 10-Q · filed 2021-08-12 | -$0.39 10-Q · filed 2020-08-07 | ||||
| 2020-03-31 | -$0.10 10-Q · filed 2021-05-14 | -$0.19 10-Q · filed 2020-05-11 | ||||||
| 2019-12-31 | -$0.16 10-K · filed 2021-03-04 | -$0.43 8-K/A · filed 2021-04-22 | -$0.70 10-K · filed 2020-03-25 | |||||
| 2019-09-30 | -$0.16 10-K · filed 2021-03-04 | -$0.54 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | -$0.17 10-K · filed 2021-03-04 | -$0.38 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | -$0.22 10-K · filed 2021-03-04 | |||||||
| 2018-12-31 | -$0.22 10-K · filed 2020-03-25 | -$1.22 10-K · filed 2021-03-04 | ||||||
| 2018-09-30 | -$0.30 10-K · filed 2020-03-25 | -$1.00 10-Q · filed 2019-11-05 | ||||||
| 2018-06-30 | -$0.35 10-K · filed 2020-03-25 | -$0.70 10-Q · filed 2019-08-06 | ||||||
| 2018-03-31 | -$0.35 10-K · filed 2020-03-25 | |||||||
| 2017-12-31 | -$0.31 10-K · filed 2019-03-13 | -$1.20 10-K · filed 2020-03-25 | ||||||
| 2017-09-30 | -$0.30 10-K · filed 2019-03-13 | -$0.89 10-Q · filed 2018-11-07 | ||||||
| 2017-06-30 | -$0.29 10-K · filed 2019-03-13 | -$0.60 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | -$0.30 10-K · filed 2019-03-13 | |||||||
| 2016-12-31 | -$0.29 10-K · filed 2018-03-12 | -$1.47 10-K · filed 2019-03-13 | ||||||
| 2016-09-30 | -$0.39 10-K · filed 2018-03-12 | -$1.18 10-Q · filed 2017-11-07 | ||||||
| 2016-06-30 | -$0.41 10-K · filed 2018-03-12 | -$0.79 10-Q · filed 2017-08-07 | ||||||
| 2016-03-31 | -$0.38 10-K · filed 2018-03-12 | |||||||
| 2015-12-31 | -$0.33 10-K · filed 2017-03-15 | -$3.31 10-K · filed 2018-03-12 | ||||||
| 2015-09-30 | -$0.60 10-K · filed 2017-03-15 | -$0.55 10-Q · filed 2015-11-12 | -$3.07 10-Q · filed 2016-11-10 | -$2.34 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | -$1.99 10-K · filed 2017-03-15 | -$1.29 10-Q · filed 2015-09-10 | -$2.58 10-Q · filed 2016-08-15 | -$1.85 10-Q · filed 2015-09-10 | ||||
| 2015-03-31 | -$0.54 10-K · filed 2017-03-15 | |||||||
| 2014-12-31 | -$0.09 10-K · filed 2016-03-30 | -$0.75 10-K · filed 2017-03-15 | ||||||
| 2014-09-30 | -$0.11 10-K · filed 2016-03-30 | -$0.56 10-Q · filed 2015-11-12 | ||||||
| 2014-06-30 | -$0.19 10-K · filed 2016-03-30 | -$0.49 10-Q · filed 2015-09-10 | ||||||
| 2014-03-31 | -$0.38 10-K · filed 2016-03-30 | |||||||
| 2013-12-31 | -$2.57 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |